VDAC2 loss elicits tumour destruction and inflammation for cancer...

@Nature shared a link

11 days ago ·

VDAC2 loss elicits tumour destruction and inflammation for cancer therapy

www.nature.com

Nature, Published online: 19 March 2025; doi:10.1038/s41586-025-08732-6VDAC2 deficiency elicits uncontrolled IFN-induced BAK activation and mitochondrial damage for improved cancer therapy.

0 Comments ·0 Shares ·65 Views

Please log in to like, share and comment!

Upgrade to Pro

Choose the Plan That's Right for You

Upgrade